Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin prophylaxis in children with newly diagnosed acute lymphoblastic leukemia
RBR-9z76pk4Phase 3Recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of levofloxacin in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Started Jul 2021; status: recruiting.
02
Drugs
levofloxacin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on RBR-9z76pk4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9z76pk4.